search
Back to results

MBCP Safety and Performance in the Osteonecrosis of Femur Head

Primary Purpose

Osteonecrosis

Status
Unknown status
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
MBCP
Sponsored by
Biomatlante
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteonecrosis focused on measuring Femur head aseptic osteonecrosis, Bone reconstruction, Macroporous biphasic calcium phosphate granules

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: femur head osteonecrosis (1 to 2 level in ARCO scale) signed informed consent Exclusion Criteria: primary bone infection femur head sphericity loss cancer, diabetes, tuberculosis previous history HIV, Hepatitis B, Hepatitis C infection drepanocytosis current corticotherapy current immunosuppressive therapy innate or acquired immune deficience pregnancy or lack of efficient contraception current participation in an other study

Sites / Locations

  • Service de chirurgie orthopédique et traumatologique- Hôpital PellegrinRecruiting

Outcomes

Primary Outcome Measures

Infection and inflammation of the drilled area (blood and clinical assessment).
Adverse events.

Secondary Outcome Measures

Pain (Analogic Visual Scale)
Hip function
Bone reconstruction evaluation through scanner and radiography

Full Information

First Posted
February 9, 2006
Last Updated
March 1, 2007
Sponsor
Biomatlante
Collaborators
CIC Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT00289575
Brief Title
MBCP Safety and Performance in the Osteonecrosis of Femur Head
Official Title
Evaluation of Safety and Performance of Macroporous Biphasic Calcium Phosphate Granules Combined With Cellulosic-Derived Gel, in Filling Bones Gap After Aseptic Osteonecrosis Biopsy of Femur Head.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2007
Overall Recruitment Status
Unknown status
Study Start Date
February 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
February 2008 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Biomatlante
Collaborators
CIC Bordeaux

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this pilot study is to evaluate MBCP performance in bone regeneration after osteonecrosis biopsy of the femur head. This technic may prevent the neck of the femur bone weakness following the healthy area drilling, thanks to a bone reconstruction at the expense of the biomaterial.
Detailed Description
Twelve patients will be enrolled in this study and evaluation of infection and inflammation of the drilled area, pain and hip function will be assessed during a one year follow up. Bone reconstruction will be evaluated with scanner and radiography.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteonecrosis
Keywords
Femur head aseptic osteonecrosis, Bone reconstruction, Macroporous biphasic calcium phosphate granules

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
12 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
MBCP
Primary Outcome Measure Information:
Title
Infection and inflammation of the drilled area (blood and clinical assessment).
Title
Adverse events.
Secondary Outcome Measure Information:
Title
Pain (Analogic Visual Scale)
Title
Hip function
Title
Bone reconstruction evaluation through scanner and radiography

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: femur head osteonecrosis (1 to 2 level in ARCO scale) signed informed consent Exclusion Criteria: primary bone infection femur head sphericity loss cancer, diabetes, tuberculosis previous history HIV, Hepatitis B, Hepatitis C infection drepanocytosis current corticotherapy current immunosuppressive therapy innate or acquired immune deficience pregnancy or lack of efficient contraception current participation in an other study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Thierry FABRE, Pr
Phone
+33556795544
Email
thierry.fabre@chu-bordeaux.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Dominique CHAUVEAUX, Pr
Phone
+33556795679
Email
dominique.chauveaux@chu-bordeaux.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thierry FABRE, Pr
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jacques DEMOTES-MAINARD, Pr
Organizational Affiliation
Clinical Research Center INSERM/Bordeaux University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Service de chirurgie orthopédique et traumatologique- Hôpital Pellegrin
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thierry FABRE, ¨Pr
Phone
+33556795544
Email
thierry.fabre@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Dominique CHAUVEAUX, pr
Phone
+33556795679
Email
dominique.chauveaux@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Thierry FABRE, Pr

12. IPD Sharing Statement

Learn more about this trial

MBCP Safety and Performance in the Osteonecrosis of Femur Head

We'll reach out to this number within 24 hrs